Taro Settles DOJ Price Fixing Charges, Will Pay $205M Penalty
Generics maker Taro Pharmaceuticals U.S.A. Inc. has agreed to pay a $205.7 million criminal penalty to settle charges that it conspired to fix prices, the U.S. Department of Justice said Thursday,...To view the full article, register now.
Already a subscriber? Click here to view full article